The DRGN ETF tracks the Beta China Generative Artificial Intelligence Select Index and is designed to provide exposure to Chinese-listed companies that derive revenue from generative AI model development and services, computing infrastructure, and related hardware activities.

It offers selective access to the generative AI theme within China's technology industry and is suited to investors who can accept elevated volatility along with country-specific risk factors.

The fund is a passive (index-tracking) ETF managed by Themes ETF.

The product screens for China-related companies with a direct business link to generative AI and weights holdings by adjusted free-float market capitalization. The index rebalancing process reflects changes in industry relevance and market value within the sector.

• Thematic exposure focused on China's generative AI industry
• Inclusion criteria spanning models and software, infrastructure, and hardware
• Index weighting based on adjusted free-float market capitalization

Assets under management (AUM) stand at $19.1M, and the total expense ratio is 0.39% annually.

Unlike broad emerging-markets products, thematic China equity funds carry a narrower industry and country exposure. Before trading, investors should review not only the fee structure but also trading volume, bid-ask spreads, the underlying market's trading hours, and the inclusion criteria.

Performance trends can be sensitive to expectations around generative AI commercialization, earnings outlooks for Chinese technology names, and shifting demand across the chip and software industries. Because the fund is highly concentrated in a single theme, individual industry news and regulatory changes can drive significant return volatility.

Fund flows are shaped by risk appetite for Chinese equities and investor interest in technology themes. Shifts in foreign-investor accessibility, policy direction, currency movements, and geopolitical factors can quickly swing flows between net inflows and net outflows, so the broader market backdrop warrants attention as well.

Concentrated exposure to China's generative AI value chain is a strength, but thematic and country concentration, along with changing trading conditions, remain core risks.

The emerging-markets comparison products listed in the table follow different strategies. The FNDE ETF takes a fundamentals-based approach to emerging-markets equities, distinguishing it from the DRGN ETF, while the FRDM ETF uses a composition that reflects a country-freedom metric. The XSOE ETF employs a methodology that lowers state-owned enterprise weightings, and the PXH ETF provides broad emerging-markets exposure grounded in fundamental factors. The EMGF ETF uses a factor-based emerging-markets approach. These products are best viewed as reference points for comparing diversification breadth and inclusion criteria rather than direct substitutes for the DRGN ETF's focused China generative AI theme.

When evaluating the DRGN ETF, investors should first clarify the purpose of their China equity exposure and the role it plays within their overall asset allocation, rather than focusing solely on the generative AI theme itself. The review process should include costs, trading conditions, distribution policy, and country-specific risks.

Share prices of China-linked technology companies can be influenced simultaneously by industry competition, policy shifts, foreign-investor accessibility, and geopolitical factors. If enthusiasm for the generative AI theme fades or the underlying assets' liquidity declines, the gap between market price and net asset value can widen.

The DRGN ETF is a thematic vehicle that can be used to gain focused exposure to China's generative AI value chain. However, because its objective differs from broad emerging-markets products, it is better viewed as a satellite allocation expressing a theme rather than a core diversifier, with the weight determined within the context of a broader asset allocation plan.